title: Intravenous versus oral busulfan-based conditioning for pediatric allogeneic hematopoietic cell transplantations: did the pendulum swing too far, too fast?
authors.affiliation: The Ottawa Hospital Blood and Marrow Transplant Program and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. Electronic address: cbredeson@ohri.ca.
authors.forename: Christopher
authors.initials: C
authors.lastname: Bredeson
mesh_terms: D002066:Busulfan / Q000008:administration & dosage*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D008297:Male; D019653:Myeloablative Agonists / Q000008:administration & dosage*; D019172:Transplantation Conditioning / Q000379:methods*
chemical_list: D019653:Myeloablative Agonists; D002066:Busulfan